| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | NPIP | 5.57e-12 | 14 | 25 | 5 | IPR009443 | |
| Domain | PRKG1_interact | 5.16e-06 | 3 | 25 | 2 | IPR031775 | |
| Domain | MYPT1/MYPT2_chordates | 5.16e-06 | 3 | 25 | 2 | IPR017401 | |
| Domain | PRKG1_interact | 5.16e-06 | 3 | 25 | 2 | PF15898 | |
| Domain | RRM | 2.95e-03 | 217 | 25 | 3 | SM00360 | |
| Domain | RRM_dom | 3.34e-03 | 227 | 25 | 3 | IPR000504 | |
| Domain | - | 4.10e-03 | 244 | 25 | 3 | 3.30.70.330 | |
| Domain | Nucleotide-bd_a/b_plait | 4.79e-03 | 258 | 25 | 3 | IPR012677 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_ROCKS | 1.13e-04 | 19 | 12 | 2 | M27493 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_CIT | 1.13e-04 | 19 | 12 | 2 | M27489 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_PAKS | 1.38e-04 | 21 | 12 | 2 | M27494 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_PKNS | 1.66e-04 | 23 | 12 | 2 | MM15216 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_PAKS | 1.66e-04 | 23 | 12 | 2 | MM15222 | |
| Pathway | WP_ENDOPLASMIC_RETICULUM_STRESS_RESPONSE_IN_CORONAVIRUS_INFECTION | 6.73e-04 | 46 | 12 | 2 | M39901 | |
| Pathway | REACTOME_REGULATION_OF_PLK1_ACTIVITY_AT_G2_M_TRANSITION | 2.28e-03 | 85 | 12 | 2 | MM14906 | |
| Pathway | REACTOME_REGULATION_OF_PLK1_ACTIVITY_AT_G2_M_TRANSITION | 2.39e-03 | 87 | 12 | 2 | M27194 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_PKNS | 2.72e-03 | 93 | 12 | 2 | M27487 | |
| Pathway | KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION | 4.13e-03 | 115 | 12 | 2 | M9387 | |
| Pathway | KEGG_SPLICEOSOME | 5.01e-03 | 127 | 12 | 2 | M2044 | |
| Pathway | WP_MRNA_PROCESSING | 5.77e-03 | 451 | 12 | 3 | MM15946 | |
| Pubmed | Novel retinal and cone photoreceptor transcripts revealed by human macular expression profiling. | 2.08e-09 | 4 | 29 | 3 | 18055785 | |
| Pubmed | Positive selection of a gene family during the emergence of humans and African apes. | 6.71e-07 | 2 | 29 | 2 | 11586358 | |
| Pubmed | Pharmacomechanical coupling: the role of calcium, G-proteins, kinases and phosphatases. | 6.71e-07 | 2 | 29 | 2 | 10087910 | |
| Pubmed | Kinases, myosin phosphatase and Rho proteins: curiouser and curiouser. | 6.71e-07 | 2 | 29 | 2 | 10200412 | |
| Pubmed | 2.01e-06 | 3 | 29 | 2 | 20801872 | ||
| Pubmed | 2.01e-06 | 3 | 29 | 2 | 10567269 | ||
| Pubmed | 4.02e-06 | 4 | 29 | 2 | 11067852 | ||
| Pubmed | 6.70e-06 | 5 | 29 | 2 | 12923170 | ||
| Pubmed | 6.70e-06 | 5 | 29 | 2 | 31883643 | ||
| Pubmed | 2.21e-05 | 1497 | 29 | 8 | 31527615 | ||
| Pubmed | 2.31e-05 | 713 | 29 | 6 | 29802200 | ||
| Pubmed | 2.66e-05 | 731 | 29 | 6 | 29298432 | ||
| Pubmed | 4.09e-05 | 233 | 29 | 4 | 37704626 | ||
| Pubmed | 4.41e-05 | 12 | 29 | 2 | 24785407 | ||
| Pubmed | 5.46e-05 | 251 | 29 | 4 | 31076518 | ||
| Pubmed | 6.03e-05 | 847 | 29 | 6 | 35850772 | ||
| Pubmed | SNIP1 Recruits TET2 to Regulate c-MYC Target Genes and Cellular DNA Damage Response. | 6.16e-05 | 259 | 29 | 4 | 30404004 | |
| Pubmed | TRIM21-mediated proteasomal degradation of SAMHD1 regulates its antiviral activity. | 1.14e-04 | 19 | 29 | 2 | 31797533 | |
| Pubmed | 1.21e-04 | 115 | 29 | 3 | 17332742 | ||
| Pubmed | Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation. | 2.21e-04 | 361 | 29 | 4 | 30344098 | |
| Pubmed | 2.69e-04 | 29 | 29 | 2 | 30228103 | ||
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | 3.58e-04 | 410 | 29 | 4 | 26949251 | |
| Pubmed | 4.91e-04 | 1247 | 29 | 6 | 27684187 | ||
| Pubmed | 5.36e-04 | 191 | 29 | 3 | 20195357 | ||
| Pubmed | 5.70e-04 | 195 | 29 | 3 | 19454010 | ||
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | 5.73e-04 | 1284 | 29 | 6 | 17353931 | |
| Pubmed | Dynamic protein-protein interaction wiring of the human spliceosome. | 5.87e-04 | 197 | 29 | 3 | 22365833 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | 5.97e-04 | 1294 | 29 | 6 | 30804502 | |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | 6.32e-04 | 477 | 29 | 4 | 31300519 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | 6.57e-04 | 1318 | 29 | 6 | 30463901 | |
| Pubmed | 7.06e-04 | 210 | 29 | 3 | 16565220 | ||
| Pubmed | SIK2 orchestrates actin-dependent host response upon Salmonella infection. | 8.02e-04 | 50 | 29 | 2 | 33947818 | |
| Cytoband | 16p13.11 | 3.98e-07 | 23 | 29 | 3 | 16p13.11 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16p13 | 6.64e-06 | 426 | 29 | 5 | chr16p13 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 5.17e-03 | 181 | 11 | 2 | 694 | |
| GeneFamily | RNA binding motif containing | 7.08e-03 | 213 | 11 | 2 | 725 | |
| GeneFamily | Ankyrin repeat domain containing | 9.06e-03 | 242 | 11 | 2 | 403 | |
| Coexpression | GSE17721_POLYIC_VS_CPG_6H_BMDC_UP | 1.73e-06 | 200 | 27 | 5 | M3943 | |
| Coexpression | GSE29617_DAY3_VS_DAY7_TIV_FLU_VACCINE_PBMC_2008_DN | 4.21e-05 | 191 | 27 | 4 | M4935 | |
| Disease | phosphatidylcholine 40:7 measurement | 5.34e-05 | 13 | 25 | 2 | EFO_0021477 | |
| Disease | lysophosphatidylcholine 20:3 measurement | 5.27e-04 | 40 | 25 | 2 | EFO_0010362 | |
| Disease | retinal nerve fibre layer thickness measurement | 6.09e-04 | 43 | 25 | 2 | EFO_0600004 | |
| Disease | cholesteryl ester 20:3 measurement | 7.91e-04 | 49 | 25 | 2 | EFO_0010347 | |
| Disease | triglycerides to total lipids in medium LDL percentage | 8.23e-04 | 50 | 25 | 2 | EFO_0022334 | |
| Disease | triglycerides to total lipids in large LDL percentage | 8.57e-04 | 51 | 25 | 2 | EFO_0022331 | |
| Disease | triglycerides to total lipids in small VLDL percentage | 1.11e-03 | 58 | 25 | 2 | EFO_0022338 | |
| Disease | retinal layer thickness measurement | 1.18e-03 | 60 | 25 | 2 | EFO_0600002 | |
| Disease | gastric carcinoma | 2.58e-03 | 89 | 25 | 2 | EFO_0000178 | |
| Disease | cholesteryl ester measurement, intermediate density lipoprotein measurement | 2.87e-03 | 94 | 25 | 2 | EFO_0008595, EFO_0010351 | |
| Disease | lipid measurement, intermediate density lipoprotein measurement | 2.99e-03 | 96 | 25 | 2 | EFO_0004529, EFO_0008595 | |
| Disease | phospholipid measurement, intermediate density lipoprotein measurement | 3.18e-03 | 99 | 25 | 2 | EFO_0004639, EFO_0008595 | |
| Disease | total cholesterol measurement, intermediate density lipoprotein measurement | 3.18e-03 | 99 | 25 | 2 | EFO_0004574, EFO_0008595 | |
| Disease | free cholesterol measurement, intermediate density lipoprotein measurement | 3.50e-03 | 104 | 25 | 2 | EFO_0008591, EFO_0008595 | |
| Disease | neuroblastoma | 4.33e-03 | 116 | 25 | 2 | EFO_0000621 | |
| Disease | lymphocyte measurement | 4.41e-03 | 117 | 25 | 2 | EFO_0803546 | |
| Disease | Intellectual Disability | 6.20e-03 | 447 | 25 | 3 | C3714756 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RRSSRVRQARAAKLS | 226 | Q9UKV3 | |
| RVKRRSRRSQVGFQQ | 111 | Q9ULA0 | |
| SKRNRRRESRSRSRS | 46 | Q9NWB6 | |
| STDVQQRARRSNRRR | 81 | Q9UND3 | |
| SKRKFSGQQRRRRNS | 1516 | O75140 | |
| RIQNSSRNTARRRLR | 751 | A0AUZ9 | |
| QNSRRRRRRVAKATA | 6 | Q9HCI5 | |
| RRVQQKSGDRTSRAR | 51 | A6NFA0 | |
| STDVQQRARRSNRRR | 81 | F8WFD2 | |
| TDVQQRARRSNRRRQ | 101 | E9PIF3 | |
| RQALSSSRRQRARNM | 61 | Q9UFP1 | |
| RRRRASSVLAQRRAQ | 41 | O14681 | |
| RNNHRARNKRGSRAR | 1586 | Q3T8J9 | |
| RTTRSASSRRRQQSR | 371 | P22004 | |
| ASSRRRQQSRNRSTQ | 376 | P22004 | |
| RRNRERNSRSGKTRC | 51 | Q4VXA5 | |
| STDVQQRARRSNRRR | 81 | E9PJI5 | |
| STDVQQRARRSNRRR | 81 | P0DM63 | |
| QSKRTVNIRTRDNRR | 676 | Q9BW92 | |
| RSQEKSLRQSRSRSR | 321 | Q08170 | |
| LRQRRSQNKFLRRQR | 441 | Q6NW34 | |
| ARRLRNARAQSRKQR | 231 | Q8TEB7 | |
| RGQRKVTVSARTNRR | 951 | Q9BPX3 | |
| GRQKTTRSRRKRNTN | 2331 | Q96T58 | |
| RQNRARESRPRRSKN | 191 | Q8IXH6 | |
| RQRRQSRSPNKERDR | 531 | B3KS81 | |
| RSRHQKRARAQAQLR | 6 | Q9NQ55 | |
| STDVQQRARRSNRRR | 81 | A6NJ64 | |
| VQRSRSKSRTRRSRS | 96 | Q96IZ7 | |
| QRKARSRQARQSRRS | 681 | O14974 | |
| LRKARSRQARQTRRS | 631 | O60237 |